Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,144 public trials 2,036 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, not recruiting

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

NCT05206357

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations
  • Lucile Packard Children's Hospital /ID# 240854 Palo Alto, California, United States
  • Nicklaus Children's Hospital /ID# 241174 Miami, Florida, United States
  • New York Medical College /ID# 239208 Valhalla, New York, United States
  • Levine Children's Hospital /ID# 242765 Charlotte, North Carolina, United States
View all 41 locations
View Trial Details
Active, not recruiting

A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

NCT05578976

Conditions
Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations
  • University of Arkansas for Medical Sciences /ID# 225703 Little Rock, Arkansas, United States
  • CBCC Global Research, Inc. /ID# 262037 Bakersfield, California, United States
  • Alta Bates Summit Medical Center for Research /ID# 229427 Berkeley, California, United States
  • Orange Coast Memorial Medical Center /ID# 229632 Fountain Valley, California, United States
View all 331 locations
View Trial Details
Active, not recruiting

A Trial for Relapsed Multiple Myeloma Patients (Isatuximab-dexamethasone)

NCT04965155

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • AOU Policlinico di Bari Bari, Italy
  • I.R.C.C.S. Ospedale S. Raffaele Milan, Italy
  • AO di Perugia-Ospedale S. Maria della Misericordia Perugia, Italy
  • Policlinico Umberto I - Università 'Sapienza' Roma, Italy
View Trial Details
Active, not recruiting

Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma

NCT01849263

Conditions
Grade 3a Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Metro Minnesota Community Oncology Research Consortium Saint Louis Park, Minnesota, United States
View all 13 locations
View Trial Details
Active, not recruiting

A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma

NCT05451810

Conditions
Classic Follicular Lymphoma, Diffuse Large B-cell Lymphoma, Disease Attributes, +14 more
Locations
  • Infirmary Health - Infirmary Cancer Care at Mobile Infirmary /ID# 264630 Mobile, Alabama, United States
  • University of Arkansas for Medical Sciences /ID# 244562 Little Rock, Arkansas, United States
  • Highlands Oncology Group, PA /ID# 245002 Springdale, Arkansas, United States
  • Beverly Hills Cancer Center /ID# 255327 Beverly Hills, California, United States
View all 72 locations
View Trial Details
Active, not recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma

NCT05201248

Conditions
B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • The Fifth Medical Center of PLA General Hospital /ID# 230520 Beijing, Beijing Municipality, China
  • Peking University Third Hospital /ID# 228138 Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital /ID# 231890 Fuzhou, Fujian, China
  • Sun Yat-Sen University Cancer Center /ID# 228033 Guangzhou, Guangdong, China
View all 18 locations
View Trial Details

Related conditions